A research brief from the Innovation and Value Initiative (IVI) sought to determine how metastatic non-small lung cancer patients’ perspectives and experiences shape cancer-related treatment decisions.
A research brief from the Innovation and Value Initiative (IVI) sought to determine how metastatic non-small lung cancer (NSCLC) patients’ perspectives and experiences shape cancer-related treatment decisions. IVI constructed in-depth interviews and focus groups with patients with metastatic NSCLC to gain insight into their perspectives on disease burden and treatment.
The research brief identified several broad themes including the need to make frequent trade-offs in treatment decisions and urgency created by the metastatic nature of disease. Patients also identified specific determinants of value in their treatment experience, including personalized care and treatments that offer tolerable side effects.
AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers
January 9th 2025In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial intelligence (AI) in cancer care.
Read More
Leveraging AI and Community Health Workers to Boost Trial Access
January 4th 2025In this second part of our interview with Kasey Bond, MPH, NYU Langone Health, we discuss the contributions of community health workers to increasing clinical trial access and how technology—artificial intelligence (AI), in particular—can help to facilitate the process.
Read More